Kenneth Dreibelbis, PA
Medical · Mobile, ALNPI 1962433862
Payments from drug & device makers
Across 47 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$161
- Shield Therapeutics Inc$97
- Novo Nordisk$96
- Idorsia Pharmaceuticals US Inc$87
- SK Life Science, Inc.$63
- Bayer$62
- plus $208 from 9 others
What the payments were for
- Food & beverage$774100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $161 |
| Shield Therapeutics Inc | 6 | $97 |
| Novo Nordisk | 6 | $96 |
| Idorsia Pharmaceuticals US Inc | 6 | $87 |
| SK Life Science, Inc. | 2 | $63 |
| Bayer | 3 | $62 |
| AstraZeneca | 4 | $58 |
| Exact Sciences | 2 | $36 |
| AbbVie | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Amgen | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$774 in reported general payments places this provider in the 55th percentile of 175 medical providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 75 | $1,090 |
| Doxycycline Hyclate | 62 | $584 |
| CefuroximeCefuroxime Axetil | 42 | $471 |
| Methylprednisolone | 42 | $404 |
| Oseltamivir Phosphate | 15 | $361 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $301 |
| Azithromycin | 49 | $297 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 19 | $293 |
| Mupirocin | 22 | $223 |
| Cephalexin | 33 | $214 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $159 |
| Hydroxyzine Hcl | 13 | $158 |
| Ciprofloxacin Hcl | 21 | $129 |
| Levofloxacin | 41 | $129 |
| Triamcinolone Acetonide | 18 | $118 |
Paid to pharmacies, not to this prescriber.
Other medical in Mobile
- Stacy RichersonMobile$12K
- Noel ZvonarMobile$5K
- Harley OliverMobile$4K
- Hannah DunnMobile$4K
- Jimmie BlanMobile$4K
- Stephanie AikinMobile$2K
- Courtney RiggsMobile$2K
- Lindsey MangumFlorence$44K
- Jaime DunnBirmingham$16K
- Susannah CashAuburn$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.